CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Jeremiah Brown, MS, MD, presents results from the phase 4 Elevatum trial investigating faricimab for diabetic macular edema.
The multicenter trial enrolled patients from underrepresented groups who identified as Black/African American and Hispanic/Latino American. Patients received six monthly injections of faricimab followed by an injection every other month out to 1 year. The results were “amazing,” according to Brown, of Retina Consultants of Texas in San Antonio.
“Consistently,